An experience with abiraterone as treatment for metastatic castration-resistant prostate cancer: Changhua christian hospital experience  by Fang, Wan-yun et al.
Abstracts / Urological Science 27 (2016) S53eS83S62Results: The mean age of the patients was 71.6 years. The mean PSA level
was 16.9 ng/ml. Prostate cancer was detected in 8 cases (23.5%): one case
by TRUS-guided biopsy alone, 2 by TURP alone, and 5 by both TRUS-guided
biopsy and TURP. Complications included fever in 5 patients (14.7%),
recatheterization for urine retention in 2 patients (5.9%) and de novo urge
incontinence in 7 patients (20.6%). The complication rate was not signiﬁ-
cantly increased when compared with the patients who underwent TURP
alone.
Conclusion: This study showed that concomitant TRUS-guided biopsy and
TURP was safe and of possible clinical signiﬁcance in urinary retention
patients with elevated PSA.
NDP034:
EXPERIENCE IN PEDIATRIC RHABDOMYOSARCOMA IN PROSTATE CASE
REPORT AND LITERATURE REVIEW
Ming-Chieh Kuo, Chia-Cheng Su, Kun-Hung Shen. Division of Urology,
Department of Surgery, Chi-Mei medical center, Tainan, Taiwan
Purpose: Rhabdomyosarcoma is a children-predominant soft tissue ma-
lignant tumor of mesenchymal origin. The overall incidence is 4.5 per 1
million children as previous literature reported. The tumor was mainly
found in head and neck ﬁeld and extremities. Since the incidence was low,
there was no well-established treatment suggestion or guidelines.
Materials and Methods: Here we present a 16-year-old boy who suffered
from acute urine retention, and was further diagnosed with prostate
embryonal rhabdomyosarcoma. With consensus made by urologist,
medical oncologist, and redio-oncologist, further treatment with concur-
rent chemoradiotherapy was arranged. Nearly complete response without
residual tumor was noted then. We also reviewed and compared the
previous literature with our current experience.
Conclusion: Pediatric rhabdomyosarcoma is a rare disease. Due to the
majority of patients was children and adolescent, aggressive CCRT
along could be well-tolerated and possible with excellent response.
Surgical intervention was remained for selected patient for further local
control.
NDP035:
MALIGNANT RENAL EPITHELIOID ANGIOMYOLIPOMA: CASE REPORT
Chun- Ming Hou, Chung-Yi Liu, Poh-Hung Lin, Yin-Hsu Chang,
Cheng-Keng Chuang, Szu-Chung Feng. Division of Urology, Department of
Surgery, Linkou Chang Gung Memorial Hospital, Department of Urology,
Taoyuan, Taiwan
We reported a 56 years oldmale patient developed signiﬁcant bodyweight
loss in 2 months. Right renal mass was noted during abdominal ultrasound
examination. Then he was referred to our urology department for further
management. Abdominal CT was arranged and showed huge right renal
mass about 13 cm with inferior vena cava tumor thrombus. We arranged
combined surgery with cardiovascular surgeon. The right radical ne-
phrectomy and inferior vena cava exploration with tumor excision were
performed. The pathology report revealed right renal malignant epithe-
lioid angiomyolipoma with negative margin.
The patient discharged without any complication 10 days after operation.
Malignant renal angiomyolipoma is rare in Taiwan even worldwide. The
radical nephrectomy alone may be inadequate due to the highly aggressive
nature of epithelioid angiomyolipoma. So adjuvant therapy with closely
follow up after operation should consider. Chemotherapy with doxoru-
bicin and cisplatin had been reported. The target therapy including
mammalian target of rapamycin (mTOR) inhibitor and sorafenib were also
reported.
Further study should be continued to conduct a standard protocol for the
adjuvant therapy of malignant epithelioid angiomyolipoma.
NDP036:
NEOVESICO-CUTANEOUS FISTULA: A CASE REPORT AND A REVIEW OF
LITERATURE
Han-Yu Wong, Wen-Horng Yang. Department of Urology, National Cheng
Kung University College of Medicine and Hospital, Tainan, TaiwanPurpose: As we know, ileal neobladder reconstruction has gained wide
acceptance and remains as one of the standard method for those with
muscle-invasive bladder cancer. However, it is associated with some spe-
ciﬁc complications and neovesico-cutaneous ﬁstula is a rare complication
which develops mostly during early postoperative period. Here, we re-
ported the case of a 84-year-old female who underwent ileal neobladder
reconstruction 19 years ago, and complicated with neovesico-cutaneous
ﬁstula with initial presentation of abdominal wall cellulitis and peritonitis.
Case Presentation: A 84-year-old female with muscle-invasive bladder
cancer underwent radical cystectomy with urinary diversion via an ileal
neobladder 19 years ago. Post-operative wound infection was noted and
debridement was later performed one month after the operation. She was
generally well with totally cancer free during these years and without
requiring clean intermittent catheterization. She presented to our emer-
gency department with right lower quadrant pain for one week. The other
associated symptoms included decreased urine output. A physical exam-
ination revealed lower abdominal skin redness and local peritoneal signs
over lower abdomen. The laboratory ﬁndings were leukocytosis with left
shifting and acute kidney injury. Contrast enhanced computed tomogra-
phy revealed a distended neobladder with subcutaneous ﬂuid accumula-
tion inn the lower abdomen. Neovesico-cutaneous ﬁstula was impressed
and urethral Foley was then inserted with turbid urine and mucus drained
out. Conservative treatment including parenteral antibiotics use and reg-
ular gentle manual irrigation were given but failed to have the ﬁstula
spontaneous closure nearly one month later. Fistulectomy was therefore
performed after discussing with general surgeon. Video-urodynamic study
was done one month after the operation which showed no more ﬁstula
tract with ileo-neobladder capacity around 200ml and a postvoid residual
urine volume of <50ml. Urethral Foley was removed after the study. The
patient has been well until now.
Conclusion: A neovesicocutaneous ﬁstula is a rare complication that occurs
after orthotopic bladder reconstruction, especially during the early post-
operative period. Conservative management including adequate, uninter-
rupted urinary drainage and broad-spectrum antibiotics therapy were
considered adequate treatment for this condition according to previous case
reports. We reported the ﬁrst case of neovesicocutaneous ﬁstula who un-
derwent surgical intervention after the above conservative treatment failed.
The result suggests that surgery is a feasible option to facilitate the closure of
a ﬁstulous tract in case of prolonged urine leakage from the ileal bladder.
NDP037:
AN EXPERIENCE WITH ABIRATERONE AS TREATMENT FOR METASTATIC
CASTRATION-RESISTANT PROSTATE CANCER: CHANGHUA CHRISTIAN
HOSPITAL EXPERIENCE
Wan-yun Fang, Hung-Jen Shih, Pai-Fu Wang. Division of Urology,
Department of Surgery, Changhua Christian Hospital, Taiwan
Purpose: To evaluate the tumor responses of abiraterone in castration-
resistant prostate cancer (CRPC) patients.
Materials and Methods: Retrospective analysis of 9 consecutive patients
with metastatic CRPC undergoing treatment with abiraterone. Treatment
effectiveness and safety analyses regarding baseline characteristics of pa-
tients (age, prior treatments, basal PSA, performance status, pain, metas-
tasis) were conducted. All patients were monitored for secondary declines
in PSA, radiological tumor regression and side effects.
Results: A total of 8 patients had a PSA decline that was conﬁrmed by a
second PSA level at least 4 weeks later. In all, 4 patients had a conﬁrmed
50% PSA decline. Treatment was well tolerated, with no grade 3 and grade
4 adverse events.
Conclusion: The treatment with abiraterone has been effective in our
series, with a tolerability considerably higher than what other studies
published.
NDP038:
SPONTANEOUS REGRESSION OF ADRENAL METASTASIS FROM RENAL
CELL CARCINOMA AFTER SUNITINIB WITHDRAWAL: CASE REPORT
AND LITERATURE REVIEW
Ti-Yuan Yang 1,2, Wun-Rong Lin 1,2, Allen W. Chiu 1,2,3. 1Department of
Urology, Mackay Memorial Hospital, Taiwan; 2Department of Medicine,
